연구동향 분석
박사

Development of pH-Independent Sustained Release Tablets Containing Carvedilol Ternary Solid Dispersion

서정웅 2016년

논문상세정보
인용/피인용
' Development of pH-Independent Sustained Release Tablets Containing Carvedilol Ternary Solid Dispersion' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Screening
  • Solid dispersion
  • carvedilol
  • solubilization
  • sustained release
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
216 0

0.0%

' Development of pH-Independent Sustained Release Tablets Containing Carvedilol Ternary Solid Dispersion' 의 참고문헌

  • Ćurić, A., Reul, R., M schwitzer, J., Fricker, G., 2013. Formulation optimization of itraconazole loaded PEGylated liposomes for parenteral administration by using design of experiments. International Journal of Pharmaceutics 448(1), 189-197.
  • van Drooge, D. J., Hinrichs, W. L. J., Visser, M. R., Frijlink, H. W., 2006. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. International Journal of Pharmaceutics 310(1–2), 220-229.
  • Zawar, L. R., Bari, S. B., 2012. Preparation, Characterization and in vivo Evaluation of Antihyperglycemic Activity of Microwave Generated Repaglinide Solid Dispersion. Chemical and Pharmaceutical Bulletin 60(4), 482-487.
  • Yuvaraja, K., Khanam, J., 2014. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid. Journal of Pharmaceutical and Biomedical Analysis 96, 10-20.
  • Yoo, S.-U., Krill, S. L., Wang, Z., Telang, C., 2009. Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multicomponent amorphous systems. Journal of Pharmaceutical Sciences 98(12), 4711-4723.
  • Wyttenbach, N., Janas, C., Siam, M., Lauer, M. E., Jacob, L., Scheubel, E., Page, S., 2013. Miniaturized screening of polymers for amorphous drug stabilization (SPADS): Rapid assessment of solid dispersion systems. European Journal of Pharmaceutics and Biopharmaceutics 84(3), 583-598.
  • Wu, P.-C., Huang, Y.-B., Chang, J. J.-F., Chang, J.-S., Tsai, Y.-H., 2000. Evaluation of pharmacokinetics and pharmacodynamics of captopril from transdermal hydrophilic gels in normotensive rabbits and spontaneously hypertensive rats. International Journal of Pharmaceutics 209(1–2), 87-94.
  • Wu, J. X., Yang, M., Berg, F. v. d., Pajander, J., Rades, T., Rantanen, J., 2011. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. European Journal of Pharmaceutical Sciences 44(5), 610-620.
  • Weuts, I., Van Dycke, F., Voorspoels, J., De Cort, S., Stokbroekx, S., Leemans, R., Brewster, M. E., Xu, D., Segmuller, B., Turner, Y. T. A., Roberts, C. J., Davies, M. C., Qi, S., Craig, D. Q. M., Reading, M., 2011. Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: Etravirine. Journal of Pharmaceutical Sciences 100(1), 260-274.
  • Wei, L., Sun, P., Nie, S., Pan, W., 2005. Preparation and Evaluation of SEDDS and SMEDDS containing carvedilol. Drug Development and Industrial Pharmacy 31(8), 785-794.
  • Wang, X., Michoel, A., Van den Mooter, G., 2005. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. International Journal of Pharmaceutics 303(1–2), 54-61.
  • Vyas, V., Sancheti, P., Karekar, P., Shah, M., Pore, Y., 2009. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharmaceutica 59(4), 453.
  • Vyas, V., Sancheti, P., Karekar, P., Shah, M., Pore, Y., 2009. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharmaceutica 59(4), 453-461.
  • Vasconcelos, T., Sarmento, B., Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today 12(23–24), 1068-1075.
  • Tran, H. T. T., Park, J. B., Hong, K.-H., Choi, H.-G., Han, H.-K., Lee, J., Oh, K. T., Lee, B.-J., 2011. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug. International Journal of Pharmaceutics 415(1–2), 83-88.
  • Tian, Y., Caron, V., Jones, D. S., Healy, A.-M., Andrews, G. P., 2014. Using Flory–Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Journal of Pharmacy and Pharmacology 66(2), 256-274.
  • Tian, B., Zhang, L., Pan, Z., Gou, J., Zhang, Y., Tang, X., 2014. A comparison of the effect of temperature and moisture on the solid dispersions: Aging and crystallization. International Journal of Pharmaceutics 475(1–2), 385-392.
  • Thongnopkoon, T., Puttipipatkhachorn, S., 2015. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate. Drug Development and Industrial Pharmacy 42(1), 70-79 .
  • Taylor, L. S., Zografi, G., 1997. Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions. Pharmaceutical Research 14(12), 1691-1698.
  • Szűts, A., L ng, P., Ambrus, R., Kiss, L., Deli, M. A., Szab -R v sz, P., 2011. Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology. International Journal of Pharmaceutics 410(1–2), 107-110.
  • Sun, Y., Tao, J., Zhang, G. G. Z., Yu, L., 2010. Solubilities of crystalline drugs in polymers: An improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. Journal of Pharmaceutical Sciences 99(9), 4023-4031.
  • Sun, Y., Fang, L., Zhu, M., Li, W., Meng, P., Li, L., He, Z., 2009. A drug-in-adhesive transdermal patch for S-amlodipine free base: In vitro and in vivo characterization. International Journal of Pharmaceutics 382(1–2), 165-171.
  • Streubel, A., Siepmann, J., Dashevsky, A., Bodmeier, R., 2000. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. Journal of Controlled Release 67(1), 101-110.
  • Sorrentino, M. J., 2003. Beta-blockers for congestive heart failure. Comprehensive Therapy 29(4), 210-214.
  • Sinha, S., Ali, M., Baboota, S., Ahuja, A., Kumar, A., Ali, J. 2010. Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir. AAPS PharmSciTech 11(2), 518-527.
  • Sharma, S., Verma, A., A. Teja, A., Shukla, P., Mishra, P. R., 2015. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies. European Journal of Pharmaceutical Sciences 69, 51-60.
  • Shanbhag, A., Rabel, S., Nauka, E., Casadevall, G., Shivanand, P., Eichenbaum, G., Mansky, P., 2008. Method for screening of solid dispersion formulations of low-solubility compounds— Miniaturization and automation of solvent casting and dissolution testing. International Journal of Pharmaceutics 351(1–2), 209-218.
  • Shamma, R. N., Basha, M., 2013. Soluplus : A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technology 237, 406-414.
  • Shamma, R. N., Basha, M., 2013. Soluplus : A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technology 237(0), 406-414.
  • Shah, S., Maddineni, S., Lu, J., Repka, M. A., 2013. Melt extrusion with poorly soluble drugs. International Journal of Pharmaceutics 453(1), 233-252.
  • Sekiguchi, K., Obi, N., Ueda, Y., 1964. Studies on Absorption of Eutectic Mixture. II. Absorption of fused Conglomerates of Chloramphenicol and Urea in Rabbits. Chemical and Pharmaceutical Bulletin 12(2), 134-144.
  • Sareen, R., Jain, N., Rajkumari, A., Dhar, K. L., 2016. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Drug Delivery 23(1), 55-62.
  • Ruffolo, R. R., Gellai, M., Hieble, J. P., Willette, R. N., Nichols, A. J., 1990. The pharmacology of carvedilol. European Journal of Clinical Pharmacology 38(s2), 82s-88s.
  • Riis, T., Bauer-Brandl, A., Wagner, T., Kranz, H., 2007. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. European Journal of Pharmaceutics and Biopharmaceutics 65(1), 78-84.
  • Puri, V., Dantuluri, A. K., Bansal, A. K., 2012. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form. Journal of Pharmaceutical Sciences 101(1), 342-353.
  • Priemel, P. A., Laitinen, R., Barthold, S., Grohganz, H., Lehto, V.-P., Rades, T., Strachan, C. J., 2013. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug–polymer mixtures. International Journal of Pharmaceutics 456(2), 301-306.
  • Prasad, D., Chauhan, H., Atef, E., 2014. Amorphous Stabilization and Dissolution Enhancement of Amorphous Ternary Solid Dispersions: Combination of Polymers Showing Drug–Polymer Interaction for Synergistic Effects. Journal of Pharmaceutical Sciences 103(11), 3511-3523.
  • Pokharkar, V. B., Mandpe, L. P., Padamwar, M. N., Ambike, A. A., Mahadik, K. R., Paradkar, A., 2006. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technology 167(1), 20-25.
  • Planinšek, O., Kovačič, B., Vrečer, F., 2011. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. International Journal of Pharmaceutics 406(1–2), 41-48.
  • Paudel, A., Van Humbeeck, J., Van den Mooter, G., 2010. Theoretical and Experimental Investigation on the Solid Solubility and Miscibility of Naproxen in Poly(vinylpyrrolidone). Molecular Pharmaceutics 7(4), 1133-1148.
  • Paidi, S. K., Jena, S. K., Ahuja, B. K., Devasari, N., Suresh, S. 2015. Preparation, in-vitro and in-vivo evaluation of spray-dried ternary solid dispersion of biopharmaceutics classification system class II model drug. Journal of Pharmacy and Pharmacology 67(5), 616-629.
  • Packer , M., Bristow , M. R., Cohn , J. N., Colucci , W. S., Fowler , M. B., Gilbert , E. M., Shusterman , N. H., 1996. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure. New England Journal of Medicine 334(21), 1349-1355.
  • Nielsen, L. H., Keller, S. S., Gordon, K. C., Boisen, A., Rades, T., M llertz, A., 2012. Spatial confinement can lead to increased stability of amorphous indomethacin. European Journal of Pharmaceutics and Biopharmaceutics 81(2), 418-425.
  • Newa, M., Bhandari, K. H., Li, D. X., Kwon, T.-H., Kim, J. A., Yoo, B. K., Woo, J. S., Lyoo, W. S., Yong, C. S., Choi, H. G. 2007. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. International Journal of Pharmaceutics 343(1–2), 228-237.
  • Nakamichi, K., Nakano, T., Yasuura, H., Izumi, S., Kawashima, Y., 2002. The role of the kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder. International Journal of Pharmaceutics 241(2), 203-211.
  • Morgan, T., Myers, J., Carney, S., 1979. The evidence that salt is an important aetiological agent, if not the cause, of hypertension. Clinical science 57(s5), 459s-462s.
  • Moes, J. J., Koolen, S. L. W., Huitema, A. D. R., Schellens, J. H. M., Beijnen, J. H., Nuijen, B., 2011. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). International Journal of Pharmaceutics 420(2), 244- 250.
  • Modi, A., Tayade, P., 2006. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 7(3), E87-E92.
  • Meng, F., Trivino, A., Prasad, D., Chauhan, H., 2015. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. European Journal of Pharmaceutical Sciences 71, 12-24.
  • Meher, J. G., Tarai, M., Yadav, N. P., Patnaik, A., Mishra, P., Yadav, K. S., 2013. Development and characterization of cellulose–polymethacrylate mucoadhesive film for buccal delivery of carvedilol. Carbohydrate Polymers 96(1), 172-180.
  • Medarević, D., Kachrimanis, K., Djurić, Z., Ibrić, S., 2015. Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin. European Journal of Pharmaceutical Sciences 78, 273-285.
  • Marshall, I. J., Wolfe, C. D. A., McKevitt, C., 2012. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ 345, 1-16.
  • Marsac, P., Li, T., Taylor, L., 2009. Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters. Pharmaceutical Research 26(1), 139-151.
  • Marsac, P., Konno, H., Taylor, L. 2006. A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems. Pharmaceutical Research 23(10), 2306-2316.
  • Maldonado, J. E., Sheps, S. G., Bernatz, P. E., DeWeerd, J. H., Harrison, E. G., 1964. Renal arteriovenous fistula. The American Journal of Medicine 37(4), 499-513.
  • Mahieu, A., Willart, J.-F., Dudognon, E., Dan de, F., Descamps, M. 2013. A New Protocol To Determine the Solubility of Drugs into Polymer Matrixes. Molecular Pharmaceutics 10(2), 560- 566.
  • Lusina, M., Cindrić, T., Tomaić, J., Peko, M., Pozaić, L., Musulin, N., 2005. Stability study of losartan/hydrochlorothiazide tablets. International Journal of Pharmaceutics 291(1–2), 127-137.
  • Lui, C. Y., Amidon, G. L., Berardi, R. R., Fleisher, D., Youngberg, C., Dressman, J. B., 1986. Comparison of gastrointestinal pH in dogs and humans: Implications on the use of the beagle dog as a model for oral absorption in humans. Journal of Pharmaceutical Sciences 75(3), 271- 274.
  • Lin, S.-Y., Lin, H.-L., Chi, Y.-T., Huang, Y.-T., Kao, C.-Y., Hsieh, W.-H., 2015. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin- Soluplus solid dispersions. International Journal of Pharmaceutics 496(2), 457-465.
  • Li, S., Wong, S., Sethia, S., Almoazen, H., Joshi, M. Y., Serajuddin, M. A. T., 2005. Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH. Pharmaceutical Research 22(4), 628-635.
  • Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., Lou, H., 2009. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. Journal of Controlled Release 133(3), 238- 244.
  • Lefort, R., De Gusseme, A., Willart, J. F., Dan de, F., Descamps, M., 2004. Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehalose. International Journal of Pharmaceutics 280(1–2), 209-219.
  • Lauer, M. E., Grassmann, O., Siam, M., Tardio, J., Jacob, L., Page, S., Kindt, J. H., Engel, A., Alsenz, J. 2010. Atomic Force Microscopy-Based Screening of Drug-Excipient Miscibility and Stability of Solid Dispersions. Pharmaceutical Research 28(3), 572-584.
  • Laitinen, R., Suihko, E., Bjorkqvist, M., Riikonen, J., Lehto, V.-P., Jarvinen, K., Ketolainen, J., 2010. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Development and Industrial Pharmacy 36(5), 601-613.
  • Lackland, D. T., Weber, M. A., 2015. Global Burden of Cardiovascular Disease and Stroke: Hypertension at the Core. Canadian Journal of Cardiology 31(5), 569-571.
  • Kyeremateng, S. O., Pudlas, M. Woehrle, G. H., 2014. A Fast and Reliable Empirical Approach for Estimating Solubility of Crystalline Drugs in Polymers for Hot Melt Extrusion Formulations. Journal of Pharmaceutical Sciences 103(9), 2847-2858.
  • Kukec, S., Dreu, R., Vrbanec, T., Srčič, S., Vrečer, F., 2012. Characterization of agglomerated carvedilol by hot-melt processes in a fluid bed and high shear granulator. International Journal of Pharmaceutics 430(1–2), 74-85.
  • Konno, H., Taylor, L. S., 2006. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. Journal of Pharmaceutical Sciences 95(12), 2692-2705.
  • Kolašinac, N., Kachrimanis, K., Homšek, I., Grujić, B., Đurić, Z., Ibrić, S., 2012. Solubility enhancement of desloratadine by solid dispersion in poloxamers. International Journal of Pharmaceutics 436(1–2), 161-170.
  • Knopp, M. M., Olesen, N. E., Holm, P., Langguth, P., Holm, R., Rades, T., 2015. Influence of Polymer Molecular Weight on Drug–Polymer Solubility: A Comparison between Experimentally Determined Solubility in PVP and Prediction Derived from Solubility in Monomer. Journal of Pharmaceutical Sciences 104(9), 2905-2912.
  • Kim, E.-J., Chun, M.-K., Jang, J.-S., Lee, I.-H., Lee, K.-R., Choi, H.-K., 2006. Preparation of a solid dispersion of felodipine using a solvent wetting method. European Journal of Pharmaceutics and Biopharmaceutics 64(2), 200-205.
  • Karavas, E., Georgarakis, E., Bikiaris, D., 2006. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. European Journal of Pharmaceutics and Biopharmaceutics 64(1), 115-126.
  • Kakran, M., Sahoo, N. G., Li, L., Judeh, Z., Wang, Y., Chong, K., Loh, L., 2010. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. International Journal of Pharmaceutics 383(1–2), 285-292.
  • Jinno, J.-i., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., Kimura, T., 2008. In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. Journal of Controlled Release 130(1), 29-37.
  • Jijun, F., Lishuang, X., Xiaoli, W., Shu, Z., Xiaoguang, T., Xingna, Z., Haibing, H., Xing, T., 2011. Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Development and Industrial Pharmacy 37(8), 934-944.
  • Janssens, S., Van den Mooter, G., 2009. Review: physical chemistry of solid dispersions. Journal of Pharmacy and Pharmacology 61(12), 1571-1586.
  • Janssens, S., Roberts, C., Smith, E. F., Van den Mooter, G., 2008. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends. International Journal of Pharmaceutics 355(1–2), 100-107.
  • Janssens, S., Nagels, S., Armas, H. N. d., D’Autry, W., Van Schepdael, A., Van den Mooter, G., 2008, Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. European Journal of Pharmaceutics and Biopharmaceutics 69(1), 158-166.
  • James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith Jr, S. C., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Narva, A. S., 2014. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8). The Journal of the American Medical Association 311(5), 507-520.
  • Jagannathan, L., Meenakshi, R., Gunasekaran, S., Srinivasan, S., 2009. FT-IR, FT-Raman and UV–vis spectra and quantum chemical investigation of carvedilol. Molecular Simulation 36(4), 283-290.
  • Hudovornik, G., Vrečer, F., 2015. Impact of the curing parameters on drug release from Eudragit RS and RL 30D coated pellets: Design of experiments. Journal of Drug Delivery Science and Technology 30, Part A, 146-153.
  • Huang, J., Wigent, R. J., Bentzley, C. M., Schwartz, J. B., 2006. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery: Effect of drug loading on release kinetics. International Journal of Pharmaceutics 319(1–2), 44-54.
  • Hu, Q., Choi, D. S., Chokshi, H., Shah, N., Sandhu, H., 2013. Highly efficient miniaturized coprecipitation screening (MiCoS) for amorphous solid dispersion formulation development. International Journal of Pharmaceutics 450(1–2), 53-62.
  • Henderson, L. S., Tenero, D. M., Baidoo, C. A., Campanile, A. M., Harter, A. H., Boyle, D., Danoff, T. M., 2006. Pharmacokinetic and Pharmacodynamic Comparison of Controlled23 Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension. The American Journal of Cardiology 98(7), 17-26.
  • Henderson, L. S., Tenero, D. M., Baidoo, C. A., Campanile, A. M., Harter, A. H., Boyle, D., Danoff, T. M., 2006. Pharmacokinetic and Pharmacodynamic Comparison of Controlled- Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension. The American Journal of Cardiology 98(7, Supplement 1), 17-26.
  • Hancock, B. C., Shamblin, S. L., Zografi, G. 1995. Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures. Pharmaceutical Research 12(6), 799-806.
  • H rter, D., Dressman, J. B., 2001. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract1. Advanced Drug Delivery Reviews 46(1–3), 75-87.
  • Guzm n, H. R., Tawa, M., Zhang, Z., Ratanabanangkoon, P., Shaw, P., Gardner, C. R., Chen, H., Moreau, J.-P., Almarsson, ., Remenar, J. F., 2007. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. Journal of Pharmaceutical Sciences 96(10), 2686-2702.
  • Grossman, E., Messerli, F. H., 2012. Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension. The American Journal of Medicine 125(1), 14-22.
  • Grohganz, H., Priemel, P. A., L bmann, K., Nielsen, L. H., Laitinen, R., Mullertz, A., Van den Mooter, G., Rades, T., 2014. Refining stability and dissolution rate of amorphous drug formulations. Expert Opinion on Drug Delivery 11(6), 977-989.
  • Goldberg, A. H., Gibaldi, M., Kanig, J. L., 1965. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures I. Theoretical considerations and discussion of the literature. Journal of Pharmaceutical Sciences 54(8), 1145- 1148.
  • Goddeeris, C., Willems, T., Houthoofd, K., Martens, J. A., Van den Mooter, G., 2008. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. European Journal of Pharmaceutics and Biopharmaceutics 70(3), 861-868.
  • Ghareeb, M. M., Abdulrasool, A. A., Hussein, A. A., Noordin, M. I., 2009. Kneading Technique for Preparation of Binary Solid Dispersion of Meloxicam with Poloxamer 188. AAPS PharmSciTech 10(4), 1206-1215.
  • Fujii, M., Okada, H., Shibata, Y., Teramachi, H., Kondoh, M., Watanabe, Y., 2005. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. International Journal of Pharmaceutics 293(1–2), 145-153.
  • Forster, A., Hempenstall, J., Tucker, I., Rades, T., 2001. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. International Journal of Pharmaceutics 226(1–2), 147-161.
  • Fong, S. Y. K., Ibisogly, A., Bauer-Brandl, A., 2015. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying. International Journal of Pharmaceutics 496(2), 382-391.
  • Engers, D., Teng, J., Jimenez-Novoa, J., Gent, P., Hossack, S., Campbell, C., Thomson, J., Ivanisevic, I., Templeton, A., Byrn, S., Newman, A., 2010. A Solid-State Approach to Enable Early Development Compounds: Selection and Animsal Bioavailability Studies of an Itraconazole Amorphous Solid Dispersion. Journal of Pharmaceutical Sciences 99(9), 3901- 3922.
  • Eloy, J. O., Marchetti, J. M., 2014. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods. Powder Technology 253, 98-106.
  • Duddu, S. P., Sokoloski, T. D., 1995. Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone)–water systems in the glassy state. Journal of Pharmaceutical Sciences 84(6), 773-776.
  • Dashevsky, A., Kolter, K., Bodmeier, R., 2004. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP. European Journal of Pharmaceutics and Biopharmaceutics 58(1), 45-49.
  • Dannenfelser, R.-M., He, H., Joshi, Y., Bateman, S., Serajuddin, A. T. M., 2004. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol– polysorbate 80 solid dispersion carrier system. Journal of Pharmaceutical Sciences 93(5), 1165- 1175.
  • Damian, F., Blaton, N., Kinget, R., Van den Mooter, G., 2002. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. International Journal of Pharmaceutics 244(1–2), 87-98.
  • D muth, B., Nagy, Z. K., Balogh, A., Vigh, T., Marosi, G., Verreck, G., Van Assche, I., Brewster, M. E., 2015. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. International Journal of Pharmaceutics 486(1–2), 268-286.
  • Crowley, M. M., Zhang, F., Repka, M. A., Thumma, S., Upadhye, S. B., Kumar Battu, S., McGinity, J. W., Martin, C., 2007. Pharmaceutical Applications of Hot-Melt Extrusion: Part I. Drug Development and Industrial Pharmacy 33(9), 909-926.
  • Couchman, P. R., Karasz, F. E., 1978. A Classical Thermodynamic Discussion of the Effect of Composition on Glass-Transition Temperatures. Macromolecules 11(1), 117-119.
  • Chiou, W. L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. Journal of Pharmaceutical Sciences 60(9), 1281-1302.
  • Carretero, O. A., Oparil, S., 2000. Essential Hypertension: Part I: Definition and Etiology. Circulation 101(3), 329-335.
  • Brewster, M. E., Loftsson, T., 2007. Cyclodextrins as pharmaceutical solubilizers. Advanced Drug Delivery Reviews 59(7), 645-666.
  • Bhugra, C., Pikal, M. J., 2008. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. Journal of Pharmaceutical Sciences 97(4), 1329-1349.
  • Baird, J. A., Taylor, L. S., 2012. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Advanced Drug Delivery Reviews 64(5), 396-421.
  • Ayenew, Z., Paudel, A., Van den Mooter, G., 2012. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen–PVP K25. European Journal of Pharmaceutics and Biopharmaceutics 81(1), 207-213.
  • Arkwright, P. D., Beilin, L. J., Rouse, I., Armstrong, B. K., Vandongen, R., 1982. Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population. Circulation 66(1), 60-66.
  • Alam, M. A., Ali, R., Al-Jenoobi, F. I., Al-Mohizea, A. M., 2012. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert Opinion on Drug Delivery 9(11), 1419-1440.
  • AlKhatib, H. S., Aiedeh, K. M., Bustanji, Y., Hamed, S., Mohammad, M. K., AlKhalidi, B., Najjar, S., 2008. Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: Implications for pH-independent release. European Journal of Pharmaceutics and Biopharmaceutics 70(3), 804-812.
  • Al-Zoubi, N. M., AlKhatib, H. S., Obeidat, W. M., 2011. Evaluation of hydrophilic matrix tablets based on Carbopol 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Development and Industrial Pharmacy 37(7), 798-808.
  • Al-Obaidi, H., Ke, P., Brocchini, S., Buckton G., 2011. Characterization and stability of ternary solid dispersions with PVP and PHPMA. International Journal of Pharmaceutics 419(1–2), 20- 27.
  • Al-Obaidi, H., Buckton, G., 2009. Evaluation of Griseofulvin Binary and Ternary Solid Dispersions with HPMCAS. AAPS PharmSciTech 10(4), 1172-1177.
  • Akimoto, M., Nagahata, N., Furuya, A., Fukushima, K., Higuchi, S., Suwa, T., 2000. Gastric pH profiles of beagle dogs and their use as an alternative to human testing. European Journal of Pharmaceutics and Biopharmaceutics 49(2), 99-102.
  • Acelajado, M. C., Calhoun, D. A., 2010. Resistant Hypertension, Secondary Hypertension, and Hypertensive Crises: Diagnostic Evaluation and Treatment. Cardiology Clinics 28(4), 639-654.